About MD PT-141

What this site is

MD PT-141 is an independent editorial project that publishes summaries of the peer-reviewed research literature on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site exists to do one thing well: read the bremelanotide record plainly and accurately. That means reporting the FDA-approved indication exactly — acquired, generalized HSDD in premenopausal women — and labeling every other use as off-label; reporting doses and pharmacokinetics as study and label findings rather than as a regimen to follow; and keeping cited clinical evidence strictly separate from the unverified community impressions we collect in clearly-marked field-reports sections.

Why "MD" is in the name

The "MD" modifier is editorial framing, not a claim about services. It signals the register we write in — a clinician's measured, instrument-grade read of the chart — not that this site is a physician, a medical practice, or a source of consultation. There is no doctor behind a desk here, no prescriptions, no telehealth, and no treatment offered. It is a position the publisher occupies relative to the literature: careful, numerate, and willing to surface the tolerability record before the efficacy pitch.

We do not invent authors or experts, claim an address or clinic, or imply a clinical team. The accuracy of the summaries, and the citations beneath every quantitative claim, are the only authority the site asserts.

How we handle the evidence

Every quantitative clinical claim on this site is tied to a numbered source on the references page — the RECONNECT Phase 3 trials, the mechanistic fMRI study, the early intranasal and subcutaneous pharmacokinetic work, the FDA prescribing information, and the NIH LiverTox monograph. Where the literature disagrees with itself — as it does on the clinical meaningfulness of the efficacy endpoints, and on a 2008 study that drew a later Expression of Concern — we say so rather than smoothing it over. Field reports are labeled as unverified, attributed to no study, and never presented as evidence or as a dose.